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Abstract
Background: Increased mast cell (MC) density and changes in their distribution in airway tissues is thought to contribute
significantly to the pathophysiology of asthma. However, the time sequence for these changes and how they impact small
airway function in asthma is not fully understood. The aim of the current study was to characterise temporal changes in
airway MC density and correlate these changes with functional airway responses in sheep chronically challenged with house
dust mite (HDM) allergen.
Methodology/Principal Findings: MC density was examined on lung tissue from four spatially separate lung segments of
allergic sheep which received weekly challenges with HDM allergen for 0, 8, 16 or 24 weeks. Lung tissue was collected from
each segment 7 days following the final challenge. The density of tryptase-positive and chymase-positive MCs (MCT and
MCTC respectively) was assessed by morphometric analysis of airway sections immunohistochemically stained with
antibodies against MC tryptase and chymase. MCT and MCTC density was increased in small bronchi following 24 weeks of
HDM challenges compared with controls (P,0.05). The MCTC/MCT ratio was significantly increased in HDM challenged
sheep compared to controls (P,0.05). MCT and MCTC density was inversely correlated with allergen-induced increases in
peripheral airway resistance after 24 weeks of allergen exposure (P,0.05). MCT density was also negatively correlated with
airway responsiveness after 24 challenges (P,0.01).
Conclusions: MCT and MCTC density in the small airways correlates with better lung function in this sheep model of chronic
asthma. Whether this finding indicates that under some conditions mast cells have protective activities in asthma, or that
other explanations are to be considered requires further investigation.
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Introduction
Asthma is a chronic inflammatory disease of the airways, which
is characterised by airway inflammation, reversible airflow
limitation and hyperresponsive airways. Mast cells (MCs) are
important mediator-secretor cells in allergic reactions and are
thought to play a major role in the pathophysiology of asthma.
Human MCs can be divided into two major groups based on their
protease content. There are those that express tryptase but not
chymase (MCT) and those that express tryptase and chymase
(MCTC). Although these two MC phenotypes are known to differ
in their tissue distribution and functional characteristics in healthy
lungs, their relative contribution to the asthmatic phenotype is not
fully understood.
It is widely established that MCs play a key role in the
pathogenesis of asthma. In particular, tryptase released by MCs
has been shown to induce airway inflammation and airway
hyperresponsiveness (AHR) [1,2,3], while MC chymase promotes
the recruitment of eosinophils and neutrophils to airway tissues
[4]. Furthermore, increased MC numbers in the airway smooth
muscle (ASM) of asthmatic patients correlates strongly with AHR
[5].
Investigations of airway changes in asthmatic patients predom-
inantly rely on airway tissue from bronchial biopsies collected from
the large proximal airways, which offers little or no information on
changes in the small peripheral airways. For mast cell-linked
research, large animal models such as primates and sheep have
been identified as being good models for chronic asthma [6,7,8,9]
because, in contrast to rodent models, they have MCT and MCTC
phenotypes distributed throughout the tracheobronchial tree [10].
In particular, sheep have a similar density of mast cells in the small
airways to that reported for humans [11] making the ovine model
relevant for studying the human disease.
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characterized progressive changes in peripheral airway responses
to chronic house dust mite (HDM) challenges using a segmental
challenge technique [12]. We found that there was a decline in
peripheral airway function with HDM exposure and that airway
responses to both allergic and non-allergic stimuli were localized to
specific treated areas of the lung. We now present an analysis of
progressive changes in mast cell density with increasing exposure
to HDM in these sheep. We also investigate the relationship
between mast cell numbers and peripheral airway function in this
large animal model of asthma.
Methods
Ethics statement
All experimental animal procedures and the collection of
tissues/cells were approved by the Animal Experimentation Ethics
Committee of the University of Melbourne (approval no. 06128).
Challenge Protocol
To investigate progressive changes in MC density we studied
archived lung tissue collected from a segmental challenge protocol
as previously described [12]. Briefly fourteen female Merino-cross
sheep (6 months) were sensitized to HDM (Dermatophagoides
pteronyssins; CLS, Melbourne, Australia) via 3 subcutaneous
injections of HDM-alum, delivered 2 weeks apart. Pre- and
post-immunisation HDM-specific serum IgE was assessed by
enzyme-linked immunosorbent assay (ELISA) and sheep with at
least a 2-fold increase were considered atopic for HDM-challenges
(n=7) [13]. Four spatially separate lung segments were identified
and challenged weekly with HDM for different durations. A fibre-
optic bronchoscope was for the delivery of solubilized HDM (1 mg
in 5 mL phosphate buffered saline [PBS]). The commencement of
challenges in each segment was staggered so that at the end of the
challenge regime the right apical, right medial, right caudal and
left caudal segments received 0, 8, 16 or 24 weeks of allergen
challenges respectively, with the last challenge in each segment
occurring 7 days prior to euthanasia. To ensure that there were no
natural differences in mast cell density between segments, a
separate group of control sheep that did not receive any HDM
treatment was used (n=7).
Bronchoalveolar lavage collection
Bronchoalveolar lavage (BAL) fluid was collected as previously
described [12]. The total number of cells collected was determined
with a haemocytometer. Differential leukocyte counts were
performed on cytospots of BAL cells stained with Haem Kwik
Differential Stains (HD Scientific, Wetherill Park, Australia) to
identify leukocytes.
Lung tissue collection, immunohistochemistry and
morphometric analysis
Sheep were euthanized by intravenous barbiturate overdose.
Lung segments were inflated with optimal cutting temperature
compound (ProSciTech, Thuringoura, Australia) diluted in PBS
(1:1). Mast cells were identified in a serial set of airway sections
were stained separately with rat anti-ovine tryptase (1:25), rat anti-
ovine chymase antibodies (1:25) (kindly provided by Prof Hugh
Miller, University of Edinburgh, UK). Eosinophils were identified
in sections stained with mouse anti-ovine galectin-14 (clone EL1.2;
Centre for Animal Biotechnology, Parkville, Australia). First,
sections were blocked for endogenous peroxidase and then
incubated with primary antibody for two hours. After washing
sections were incubated with swine anti-rat HRP conjugated
secondary antibody (1:100; Dako, Kingsgrove, Australia). Sections
were then washed and a peroxidase based detection system was
used for visualization [11]. Specificity of staining was confirmed by
omission of the primary antibody.
All morphometric measurements of the airways were made
using digital image analysis (Image-Pro Plus, Media Cybernetics,
version 4.1.0.0). The area of the airway wall was determined by
the area enclosed by the outer perimeter of the basement
membrane (BM) and the outer perimeter of the airway wall as
previously described [14]. Two small cartilaginous bronchi
(approximately 1–2 mm diameter) from each segment in each
sheep were examined and the two values averaged. Results are
expressed as the number of positive cells per mm
2 of airway wall.
Collagen and ASM content was measured on sections stained with
a Masson’s Trichrome stain kit (Sigma-Aldrich, Australia), as
previously described [11]. Results are expressed as the area of
collagen or ASM per mm BM. All sections were scored by a single
observer who was blind to the experimental group and lung
segment.
Lung function correlations
Segmental lung function indices were taken from a separate
study performed on these sheep [12] and used to determine the
relationship between MC density and functional airways changes.
Data analysis
Statistical analysis was performed with GraphPad Prism
software (version 4.01, GraphPad, San Diego, CA, USA). Mast
cell density values reported are the mean 6 standard error. Mann-
Whitney U tests compared mast cell density between the control
and HDM-challenge groups. Correlations were assessed by the
Spearman correlation coefficient (rs). A P value of ,0.05 was taken
as significant.
Results
Mast cell density
Results show that at least 16 weekly HDM challenges are
required to increase the density of mast cells in the airway wall.
MCT density in the airway wall of bronchi was significantly
increased in HDM challenged segments that received 16 and 24
challenges compared to the corresponding segments in the control
group (86621 vs. 4368, P,0.05 and 71611 vs. 3668 cells/mm
2
respectively, P,0.05; Fig. 1). The mast cells were predominantly
located in the outer walls of small bronchi as illustrated in Figure 2.
There was no difference in MCT density in segments from HDM-
challenged sheep that received 8 challenges compared to control
sheep (Fig. 1). A correlation analysis revealed that MCT density in
bronchi was significantly positively correlated to the duration in
weeks of HDM challenges (rs=0.510, P,0.01; data not shown).
MCTC density in the left caudal lung segment of the HDM-
challenged group was significantly increased following 24 weeks of
challenges compared to the control group (5268 vs. 864 cells/
mm
2,P ,0.01; Fig. 3a). The MCTC/MCT ratio was significantly
increased the HDM-challenged group compared to the control
group (0.78460.152 vs. 0.28860.105, P,0.05; Fig. 3b).
Correlation analysis between mast cells and small airway
function
Next we tested whether increased mast cell density in the small
airways was correlated to the lung function indices reported in our
previous study. MCT density in bronchi after 24 weeks of
challenges was significantly negatively correlated with the peak
early-phase airway response (EAR); i.e. percent increase in Rp
Mast Cells and Peripheral Airway Function
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Fig. 4a). There was no correlation between MC density and EAR
at any of the other time-points (data not shown). MCTC density
after 24 weeks of HDM challenges was also negatively correlated
with early-phase responses (rs=20.82, P,0.05; Fig. 4b).
The percent dose of methacholine required for a 100% increase
in Rp (PC100) was positively correlated with MCT (rs=0.92,
P,0.01; Fig. 5a). There was also a strong trend for a positive
correlation between MCTC density and the dose of methacholine
for PC100 (rs=0.74, P=0.066; Fig. 5b). There was no correlation
between MC density and airway responsiveness to methacholine
at any of the other time-points. Nor was there any correlation
between MCT or MCTC density and methacholine for PC100 in
the untreated control sheep (rs=20.197, P=0.662 and rs=0.060,
P=0.903 respectively).
Airway remodeling
There was no significant difference in the amount of ASM in
the lung segment that received 24 weeks of HDM compared to the
corresponding segment in controls (0.02960.005 vs.
0.02560.004 mm
2/BM; Fig. 6a). However, there was a significant
increase in the amount of collagen (0.1760.02 vs.
0.1160.02 mm
2/BM, P,0.05 Fig. 6b). There was a trend for
the increase in collagen to be associated with increasing MCTC
density (rs=0.71, P=0.088). The amount of airway collagen also
tended to be negatively associated with EAR (rs=20.75,
P=0.066).
Inflammatory cells
There was a significant increase in the density of eosinophils in
the airway walls following 24 weeks of HDM challenges compared
to the corresponding segment in controls (64.9619.4 vs. 10.963.1,
P,0.01; Figure 6c). There was no correlation between eosinophil
density and MCT or MCTC concentration in HDM-challenged or
unchallenged airways (rs=0.17, P=0.713 and rs=0.57, P=0.200;
data not shown). Nor was there a correlation between eosinophil
numbers and functional indices; i.e. EAR and PC100(MCh) in the
HDM challenged segment (rs=20.071, P=0.906 and rs=0.20,
P=0.662 respectively, data not shown). Table 1 shows that the
number of eosinophils and other inflammatory cells was increased
in the BAL 48 hours post-HDM at week 20 compared to the level
prior to challenge. However, there was no correlation between any
of the cell types examine and MC numbers, or functional indices
(data not shown).
Figure 1. Tryptase-positive mast cell (MCT) density following
challenge with house dust mite (HDM) allergen. Bars show the
number of MCT per mm
2 in the airway wall of bronchi in four spatially
separate lung segments from control and HDM challenged groups. The
number in italics indicates the number of HDM challenges each lung
segment received. Line shows the mean, boxes show 25
th and 75
th
percentile, whiskers represent 5
th to 95
th percentile. n=7, *P,0.05. R –
right; L – left.
doi:10.1371/journal.pone.0037161.g001
Figure 2. Airway sections stained with antibodies against mast cell tryptase and chymase. (a) Tryptase-positive mast cells and (b)
chymase-positive mast cells. The house dust mite (HDM) treated segment received 24 weekly challenges and the control segment was untreated.
Negative control shows omission of the primary antibody. Arrows indicate positive cells.
doi:10.1371/journal.pone.0037161.g002
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While mast cells have long been implicated in the pathophys-
iology of asthma, very few studies have systematically examined
the effects of mast cells on small airway function. To our
knowledge this is the first time that the temporal dynamics of the
mast cell population has been examined in the lungs in a large
animal model of asthma. The key findings from this study are that
MCT and MCTC density increased significantly following chronic
allergen challenge and that MC density is positively correlated
with the length allergen exposure and improved airway responses
to allergic and non-specific stimuli.
It is noteworthy that the proportion of MCs with the chymase
phenotype increases markedly with allergic challenge. Our result
confirms a previous study in sheep where airways exposed to
allergen have increased density of MCTC [15] and is consistent the
finding of increased MCTC in the small airways of asthmatics [16].
It cannot be deduced from our results whether the MCTC were
converted from existing MCT phenotype or were differentiated
from newly infiltrating mast progenitor cells which originated in
the bone marrow. Early studies examining mast cells developed in
vitro from human fetal liver cells, and/or cord blood, suggest that
commitment to develop as an MCT or MCTC phenotype may
occur in MC precursor cells and that there is no evidence for
conversion of MCT to MCTC in mature mast cells [17]. However,
other in vitro studies provide evidence for phenotype conversion in
that MCTC co-cultured with human airway epithelial cells are
known to convert to the MC phenotype [18,19], suggesting that
this may also be a possibility in the ovine in vivo experiments
presented here.
Interestingly, in the present study we found a positive
correlation between increased MC density and small airway
function. This finding was surprising at first, given the well
acknowledged central role of airway mast cells in orchestrating
allergic inflammatory responses in asthma [20]. However, a close
examination of the literature reveals that a positive relationship
between mast cell density and lung function has been previously
reported in two separate clinical studies of asthma [16,21] and also
Figure 3. Chymase-positive mast cell (MCTC) density increases following chronic allergen challenge. (a) MCTC per mm
2 of airway wall (b)
ratio of MCTC and tryptase-positive mast cells (MCT). The house dust mite (HDM) treated segment received 24 weekly challenges and the control
segment was untreated. Line shows the mean, boxes show 25
th and 75
th percentile, whiskers represent 5
th to 95th percentile. n=7, *P,0.05,
**P,0.01 compared to controls.
doi:10.1371/journal.pone.0037161.g003
Figure 4. Relationship between mast cell density and peak early bronchoconstriction response. Correlation between the percentage
increase in peripheral resistance (Rp) 30 minutes post-HDM challenge and (a) MCT (rs=20.89, P,0.05) and (b) MCTC (rs=20.82, P,0.05).
doi:10.1371/journal.pone.0037161.g004
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[22,23]. In asthma in particular, MCTC density in the small
airways is correlated with improved lung function in mild-to-
moderate and severe asthmatic subjects [16,21]. It is unknown
whether the aforementioned studies indicate that under some
conditions mast cells possess protective activities in allergic airways
or if other possibilities are to be considered.
One possible explanation for this correlation is that the higher
concentration of MCs observed in individuals with the best airway
function reflects a lower degree of degranulation and thus, a less
deleterious effect. In support of this hypothesis are reports that
patients who have died from asthma have a lower number of MCs
in their airways compared to control cases [24] and that MC
degranulation is positively associated with disease severity [25] and
hence, poorer lung function.
As suggested by others, it is also conceivable that in addition to
their harmful activities, MCs offer some protection against
deteriorating lung function in states of disease [16]. In particular,
the positive relationship between MCs and lung function could
reflect an adaptive response of MCs to down-regulate some of
their pro-inflammatory activities [26]. In support of this is the
finding that mouse MC protease 4 (MCP-4), a chymase that is
functionally homologous to human chymase, has a protective role
in allergic airway inflammation [26]. Mice lacking MCP-4 were
found to have significantly higher AHR and airway inflammation
when sensitized and challenged with ovalbumin compared with
their wild type counterparts [26].
It has been previously suggested that MCs may be able to exert
protective effects by regulating ASM cells [26]. In particular, MC
chymase has been shown to inhibit smooth muscle cell prolifer-
ation and thus, may prevent the associated increase in peripheral
airway resistance in chronic disease [27]. It is possible that MC
regulation of the ASM cells could explain the lack of an increase in
ASM area in HDM challenged sheep relative to controls observed
in the current study.
Another possibility is that the release of MC tryptase has some
long-term protective effects for lung function by stabilising lung
structure. For example, tryptase has been reported to repair and
remodel damaged airway tissues in asthmatic lungs [28]. The
release of tryptase into the airways has been suggested to drive
fibrosis and extracellular matrix turnover [29], particularly the
synthesis and secretion of type I collagen [29], potentially
contributing to a stiffening of the bronchial walls and the
prevention of airway collapse on expiration, thereby serving a
protective function in diseased airways [30,31]. Consistent with
this hypothesis is the finding from our study that bronchial
Figure 5. Relationship between mast cell density and airway responsiveness. Correlation between the percent dose of methacholine
required to increase Rp by 100% (PC100[MCh]) from baseline and (a) MCT (rs=0.92, P,0.01) and (b) MCTC.
doi:10.1371/journal.pone.0037161.g005
Figure 6. Airway remodeling and eosinophils following chronic allergen challenge. (a) Airway smooth muscle (ASM) per mm basement
membrane (BM) length (b) collagen area per mm BM and (c) eosinophils per mm
2 airway wall, in untreated control sheep and sheep challenged with
house dust mite (HDM) allergen weekly for 24 weeks. Line shows the mean, boxes show 25th and 75th percentile, whiskers represent 5th to 95th
percentile. n=7, *P,0.05, ***P,0.001 compared to controls.
doi:10.1371/journal.pone.0037161.g006
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allergen challenges, and that amount airway wall collagen tended
to be positively associated with MCTC density.
It is important to note that therapeutic interventions against
mast cell activation are likely to be important when mast cells are
active in coordinating the detrimental immune response at the
onset of the allergic reaction. However, the findings from the
present study and that of Balzar et al [16], Zanini et al [21] and
Gosman et al [22], that increased numbers of mast cells are
associated with relatively better lung function in diseased airways,
suggest that any therapeutic interventions that are active against
mast cells will also need to accommodate this aspect in long-term
management of airway disease.
In the present study we show a correlation between mast cell
density and better airway responses to allergic and non-allergic
stimuli in a large animal model. Our results support the findings of
several clinical studies that report positive correlations between
increased mast cell concentrations and improved lung function
indices. Whether this finding indicates that under some conditions
MCs have protective activities in asthma, or that other explana-
tions are to be considered, requires further investigation.
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Table 1. Leukocyte composition of bronchoalveolar lavage
cells.
Before HDM 48 hrs post-HDM
Mean SEM Mean SEM
Neutrophils 6.4 2.4 4.1 1.3
Eosinophils 0.4 0.3 225.8 95.4
Lymphocytes 17.1 7.9 21.4 4.9
Macrophages 152.0 36.5 141.4 34.5
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were performed on cytospots of BAL cells. Values shown are cells (610
5)p e rm L
BAL retrieved. n=6.
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